RPGRIP1L and neoplasm: Functional studies demonstrated that RPGRIP1L knockdown reduced genomic instability in tumor cells, as evidenced by decreased Phosphorylated Histone H2AX (γH2AX) expression, and suppressed tumor growth in mouse models.